跳至主要内容
临床试验/CTRI/2018/03/012871
CTRI/2018/03/012871招募中未知

Evaluation of the Efficacy of Sharbat-e-Unnab in Primary Hypertension.-An open labeled randomized standard controlled study.

ational Institute of Unani Medicine0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Known case of Primary hypertension with or without medication.
  • Patients with H/O hypertension (stage-1 hypertension, ranging between systolic pressure 140 mm Hg to 159 mm Hg and/or diastolic pressure 90 mm Hg to 99 mmHg) as per reference card from (JNC-7).
  • Age between 35 to 50 years.
  • Both Gender.

排除标准

  • Patients below 35 and above 50 years of age.
  • Pregnancy and Lactation.
  • Secondary Hypertension.
  • Diabetes Mellitus.
  • Other systemic and metabolic disorders.
  • History of Myocardial Infarction and Ischemic Heart Disease.
  • Bronchial Asthma and COPD.

研究者

发起方
ational Institute of Unani Medicine

相似试验